Dual Antiplatelet Therapy (DAPT) Score
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Score (<2)-10–1
- High Score (≥2)2–20
The Dual Antiplatelet Therapy (DAPT) Score calculates predicting which patients will benefit from prolonged DAPT after coronary stent placement. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts which patients will benefit from prolonged DAPT after coronary stent placement. Developed from the DAPT Study randomized trial to predict combined ischemic and bleeding risk for patients being considered for continued thienopyridine therapy beyond 1 year.
Clinical Indication
The Dual Antiplatelet Therapy (DAPT) Score is indicated for bedside clinical practice to support Predicts which patients will benefit from prolonged DAPT after coronary stent placement. Developed from the DAPT Study randomized trial to predict combined ischemic and bleeding risk for patients being considered for continued thienopyridine therapy beyond 1 year.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
DAPT Score = Age points + Clinical factors. Age: 65-75 years (-1 pt), ≥75 years (-2 pts). Positive factors: Diabetes (+1 pt), Current smoking (+1 pt), Prior MI/PCI (+1 pt), Stent diameter <3mm (+1 pt), CHF/LVEF <30% (+2 pts), Vein graft PCI (+2 pts), Paclitaxel-eluting stent (-1 pt), MI at presentation (+1 pt).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| diabetes_mellitus | string | Yes | History of diabetes mellitus |
| current_smoking | string | Yes | Current cigarette smoking |
| prior_mi_or_pci | string | Yes | Prior myocardial infarction or prior percutaneous coronary intervention |
| stent_diameter_small | string | Yes | Stent diameter <3 mm |
| chf_or_low_ef | string | Yes | History of congestive heart failure or left ventricular ejection fraction <30% |
| vein_graft_pci | string | Yes | Saphenous vein graft PCI |
| paclitaxel_eluting_stent | string | Yes | Paclitaxel-eluting stent |
| mi_at_presentation | string | Yes | Myocardial infarction at presentation |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -10–1 | Low Score (<2) | Unfavorable benefit/risk ratio |
| 2–20 | High Score (≥2) | Favorable benefit/risk ratio |
Evidence-Based References (EBM)
- Yeh RW, Secemsky EA, Kereiakes DJ, Normand SLT, Gershlick AH, Cohen DJ, et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735-49. doi: 10.1001/jama.2016.3775.DOI: 10.1001/jama.2016.3775
- Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. Circulation. 2016;134(10):e123-55. doi: 10.1161/CIR.0000000000000404.DOI: 10.1161/CIR.0000000000000404
- Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.DOI: 10.1016/S0140-6736(17)30397-5